Shape-controlled hollow Cu2OCuS nanocubes with enhanced photocatalytic activities towards degradation of tetracycline
In view of recent advances in photodegradation of antibiotics, low cost and stable photocatalyst remain rare. In this article, shape-controlled Cu2OCuS nanocubes with the larger specific surface area were successfully prepared via a simple template-engaged strategy. Cu2O nanocubes were synthesized t...
Veröffentlicht in: | Environmental technology. - 1993. - 44(2023), 18 vom: 02. Aug., Seite 2702-2712 |
---|---|
1. Verfasser: | |
Weitere Verfasser: | , , , , , , |
Format: | Online-Aufsatz |
Sprache: | English |
Veröffentlicht: |
2023
|
Zugriff auf das übergeordnete Werk: | Environmental technology |
Schlagworte: | Journal Article Cu2O@CuS Photocatalytic activities nanocubes shape-controlled tetracycline Anti-Bacterial Agents Sulfur 70FD1KFU70 Tetracycline |
Zusammenfassung: | In view of recent advances in photodegradation of antibiotics, low cost and stable photocatalyst remain rare. In this article, shape-controlled Cu2OCuS nanocubes with the larger specific surface area were successfully prepared via a simple template-engaged strategy. Cu2O nanocubes were synthesized through a reduction method as original templates, the core-shelled Cu2O@CuS nanocubes were formed by sulphuration with Na2S as sulphur source, and the Cu2O core can be incompletely removed by Na2S2O3 to generate the Cu2O@CuS nanoboxes. Herein, hierarchical nanoboxes with two-layered Cu2O@CuS were used as photocatalyst materials for photocatalytic degradation of tetracycline (TC). The obtained nanocubes manifested high specific surface area (39.65 m2 g-1) and large pore volume (12.3 cm3 g-1). The degradation performance for TC was investigated in detail, including the effect of parameters such as photocatalyst, pH and catalyst dosage. The results indicated that degradation efficiencies were higher than 90% under visible light. Moreover, the degradation efficiency was 71% after six times |
---|---|
Beschreibung: | Date Completed 17.11.2023 Date Revised 17.11.2023 published: Print-Electronic Citation Status MEDLINE |
ISSN: | 1479-487X |
DOI: | 10.1080/09593330.2022.2041102 |